BioTeZ Berlin-Buch GmbH aus Berlin auf der MEDICA 2018 in Düsseldorf -- MEDICA - Weltforum der Medizin
Hersteller Dienstleister OEM

BioTeZ Berlin-Buch GmbH

Robert-Rössle-Str. 10, 13125 Berlin
Deutschland
Telefon +49 30 94892130
Fax +49 30 9494509
info@biotez.de

Dieser Aussteller ist Mitaussteller von
DiagnostikNet-BB Netzwerk Diagnostik Berlin-Brandenburg e.V.

Hallenplan

MEDICA 2018 Hallenplan (Halle 3): Stand G54

Geländeplan

MEDICA 2018 Geländeplan: Halle 3

Ansprechpartner

Dr. Janko Brand

Uwe Ahnert

Besuchen Sie uns!

Halle 3 / G54

12.11.2018

Thema

Download

ganztägig

Tutorial and Demonstration of the Therapeutic Drug Monitoring recoveryELISA

Therapeutic Drug Monitoring (TDM) solutions: The patented recoveryELISA technology allows multi-parameter measurements supporting dose finding, pharmacokinetic and pharmacodynamics studies leading to personalized medicine and diagnostic approaches. The recoveryELISA is established for PCSK9 and Evolocumab; Adalimumab/Infliximab and TNFa as well as Omalizumab and IgE. A customization for your biological and antigen can be discussed on site.

Mehr Weniger

13.11.2018

Thema

Download

ganztägig

Tutorial and Demonstration of the Therapeutic Drug Monitoring recoveryELISA

Therapeutic Drug Monitoring (TDM) solutions: The patented recoveryELISA technology allows multi-parameter measurements supporting dose finding, pharmacokinetic and pharmacodynamics studies leading to personalized medicine and diagnostic approaches. The recoveryELISA is established for PCSK9 and Evolocumab; Adalimumab/Infliximab and TNFa as well as Omalizumab and IgE. A customization for your biological and antigen can be discussed on site.

Mehr Weniger

14.11.2018

Thema

Download

ganztägig

Tutorial and Demonstration of the Therapeutic Drug Monitoring recoveryELISA

Therapeutic Drug Monitoring (TDM) solutions: The patented recoveryELISA technology allows multi-parameter measurements supporting dose finding, pharmacokinetic and pharmacodynamics studies leading to personalized medicine and diagnostic approaches. The recoveryELISA is established for PCSK9 and Evolocumab; Adalimumab/Infliximab and TNFa as well as Omalizumab and IgE. A customization for your biological and antigen can be discussed on site.

Mehr Weniger

15.11.2018

Thema

Download

ganztägig

Tutorial and Demonstration of the Therapeutic Drug Monitoring recoveryELISA

Therapeutic Drug Monitoring (TDM) solutions: The patented recoveryELISA technology allows multi-parameter measurements supporting dose finding, pharmacokinetic and pharmacodynamics studies leading to personalized medicine and diagnostic approaches. The recoveryELISA is established for PCSK9 and Evolocumab; Adalimumab/Infliximab and TNFa as well as Omalizumab and IgE. A customization for your biological and antigen can be discussed on site.

Mehr Weniger

Unser Angebot

Produktkategorien

  • 03  Diagnostika
  • 03.01  Klinische Chemie
  • 03.01.04  Schnelltests in der klinischen Chemie

Schnelltests in der klinischen Chemie

  • 03  Diagnostika
  • 03.02  Immunochemie / Immunologie
  • 03.02.01  Immun-Assay-Systeme

Immun-Assay-Systeme

  • 03  Diagnostika
  • 03.02  Immunochemie / Immunologie
  • 03.02.02  Diagnose-Schnelltests

Diagnose-Schnelltests

  • 03  Diagnostika
  • 03.02  Immunochemie / Immunologie
  • 03.02.04  Sonstige Geräte zur Immunochemie / Immunologie

Sonstige Geräte zur Immunochemie / Immunologie

Über uns

Firmenporträt

We are your partner for Immunochemistry Solutions & Assay Manufacturer! We are experts in Assay Development/ Validation (various formats) and also OEM Manufacturer for individual Kit Components/ Coatings/ Conjugates (Poly-HRP, Europium etc.)/ Customized Microplates; Immobilization Systems: unique Tags/ Streptavidin/ high capacity Polystrept for Quick Test Membranes or other surfaces; ELISA; Therapeutic Drug Monitoring Biologics: Evolocumab/PCSK9 (Cardio Vascular ), Omalizumab/IgE (Allergy), Adalimumab/TNFa (Rheumatism); We Customiz Gels & Columns for Affinity Chromatography: Mycotoxin/Vitamin Clean-up Columns; DNA/RNA Primer Synthesis incl. Modifications; Drug Discovery: Human Proteases/ Enzymes/ Proteins; Enzyme Activity Assays; Parkinson Diagnostics: COMT, MAO-B, DDC & Inhibitors

Mehr Weniger

Unternehmensdaten

Umsatz

1-9 Mio US $

Exportanteil

max. 75%

Anzahl der Beschäftigten

20-49

Gründungsjahr

1992

Geschäftsfelder
  • Labortechnik
  • Diagnostika